Related references
Note: Only part of the references are listed.Marine Pharmacology in 2009-2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of Action
Alejandro M. S. Mayer et al.
MARINE DRUGS (2013)
Antioxidant, Anti-inflammatory, and Anti-senescence Activities of a Phlorotannin-Rich Natural Extract from Brown Seaweed Ascophyllum nodosum
Melody Dutot et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2012)
Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae
Isuru Wijesekara et al.
CARBOHYDRATE POLYMERS (2011)
Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae
Felix Nwosu et al.
FOOD CHEMISTRY (2011)
Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes
Chang-Suk Kong et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
The pharmaceutical value of marine biodiversity for anti-cancer drug discovery
Patrick M. Erwin et al.
ECOLOGICAL ECONOMICS (2010)
Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders
Francisco A. Villa et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Anti-HIV-1 efficacy of extracts from medicinal plants
Su-A Lee et al.
JOURNAL OF MICROBIOLOGY (2010)
Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
Y. Jiang et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Development of Novel Drugs from Marine Surface Associated Microorganisms
Anahit Penesyan et al.
MARINE DRUGS (2010)
Chemical components and its antioxidant properties in vitro: An edible marine brown alga, Ecklonia cava
Yong Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
Erik De Clercq
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava
Murat Artan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and antiviral properties of some polyphenols related to Salvia genus
Clemence Queffelec et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
HIV drug development: the next 25 years
Charles Flexner
NATURE REVIEWS DRUG DISCOVERY (2007)
New aspects of natural products in drug discovery
Kin S. Lam
TRENDS IN MICROBIOLOGY (2007)
Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity
Moon-Moo Kim et al.
LIFE SCIENCES (2006)
Phloroglucinol compounds of natural origin
Inder Pal Singh et al.
NATURAL PRODUCT REPORTS (2006)
Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors
DS Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava
MJ Ahn et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome
K Nagayama et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
